328 related articles for article (PubMed ID: 30734604)
1. Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.
Lopes PH; Murakami MT; Portaro FCV; Mesquita Pasqualoto KF; van den Berg C; Tambourgi DV
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):310-321. PubMed ID: 30734604
[TBL] [Abstract][Full Text] [Related]
2. Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation.
Lopes PH; Bertani R; Gonçalves-de-Andrade RM; Nagahama RH; van den Berg CW; Tambourgi DV
PLoS Negl Trop Dis; 2013; 7(8):e2394. PubMed ID: 23991242
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelinase D Activity in
Lopes PH; Fukushima CS; Shoji R; Bertani R; Tambourgi DV
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916208
[TBL] [Abstract][Full Text] [Related]
4. Role of the complement system in kidney cell death induced by Loxosceles venom Sphingomyelinases D.
Okamoto CK; van den Berg CW; Pohl PC; Tambourgi DV
Arch Toxicol; 2024 May; 98(5):1561-1572. PubMed ID: 38498159
[TBL] [Abstract][Full Text] [Related]
5. Searching for the toxic potential of Loxosceles amazonica and Loxosceles willianilsoni spiders' venoms.
Lopes PH; Fukushima CS; Shoji R; Bertani R; Tambourgi DV
Toxicon; 2021 Feb; 191():1-8. PubMed ID: 33347860
[TBL] [Abstract][Full Text] [Related]
6. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom.
Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV
J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940
[TBL] [Abstract][Full Text] [Related]
7. Role of ErbB and IL-1 signaling pathways in the dermonecrotic lesion induced by Loxosceles sphingomyelinases D.
Pinto BF; Lopes PH; Trufen CEM; Ching ATC; De Azevedo ILMJ; Nishiyama MY; Pohl PC; Tambourgi DV
Arch Toxicol; 2023 Dec; 97(12):3285-3301. PubMed ID: 37707622
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and genotoxic effects on human keratinocytes triggered by sphingomyelinase D from Loxosceles venom.
da Silva MS; Lopes PH; Elias MC; Tambourgi DV
Arch Toxicol; 2020 Oct; 94(10):3563-3577. PubMed ID: 32607614
[TBL] [Abstract][Full Text] [Related]
9. Loxosceles venom Sphingomyelinase D activates human blood leukocytes: Role of the complement system.
Manzoni-de-Almeida D; Squaiella-Baptistão CC; Lopes PH; van den Berg CW; Tambourgi DV
Mol Immunol; 2018 Feb; 94():45-53. PubMed ID: 29257998
[TBL] [Abstract][Full Text] [Related]
10. SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis.
de Santi Ferrara GI; Fernandes-Pedrosa Mde F; Junqueira-de-Azevedo Ide L; Gonçalves-de-Andrade RM; Portaro FC; Manzoni-de-Almeida D; Murakami MT; Arni RK; van den Berg CW; Ho PL; Tambourgi DV
Toxicon; 2009 Jun; 53(7-8):743-53. PubMed ID: 19249326
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinase D from Loxosceles laeta Venom Induces the Expression of MMP7 in Human Keratinocytes: Contribution to Dermonecrosis.
Corrêa MA; Okamoto CK; Gonçalves-de-Andrade RM; van den Berg CW; Tambourgi DV
PLoS One; 2016; 11(4):e0153090. PubMed ID: 27078876
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom.
Fernandes Pedrosa Mde F; Junqueira de Azevedo Ide L; Gonçalves-de-Andrade RM; van den Berg CW; Ramos CR; Ho PL; Tambourgi DV
Biochem Biophys Res Commun; 2002 Nov; 298(5):638-45. PubMed ID: 12419302
[TBL] [Abstract][Full Text] [Related]
13. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
[TBL] [Abstract][Full Text] [Related]
14. First report of in vitro selection of RNA aptamers targeted to recombinant Loxosceles laeta spider toxins.
Sapag A; Salinas-Luypaert C; Constenla-Muñoz C
Biol Res; 2014 Mar; 47(1):2. PubMed ID: 25027855
[TBL] [Abstract][Full Text] [Related]
15. Tetracycline Reduces Kidney Damage Induced by Loxosceles Spider Venom.
Okamoto CK; van den Berg CW; Masashi M; Gonçalves-de-Andrade RM; Tambourgi DV
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28257106
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom.
de Andrade SA; Murakami MT; Cavalcante DP; Arni RK; Tambourgi DV
Toxicon; 2006 Mar; 47(4):380-6. PubMed ID: 16458340
[TBL] [Abstract][Full Text] [Related]
17. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
[TBL] [Abstract][Full Text] [Related]
18. Partial in vivo protection against Peruvian spider Loxosceles laeta venom by immunization with a multiepitopic protein (rMEPLox).
Quispe RL; Jaramillo ML; Torres-Huaco F; Bonilla C; Isasi J; Guerra-Duarte C; Chávez-Olórtegui C
Toxicon; 2022 Aug; 215():1-5. PubMed ID: 35660625
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
20. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
